Trifene 400

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trifene 400

Property Description
Active ingredient Ibuprofen
Form Oral Film-Coated Tablet
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic Propionic acid derivative

Trifene 400 is an oral medicinal product classified as a Nonsteroidal Anti-inflammatory Drug (NSAID), which is formulated to offer symptomatic relief through its primary actions against pain, fever, and inflammation. The identity of this medication is defined by its single, synthetic active ingredient, which belongs to the Propionic acid derivative subclass of pharmaceuticals. The efficacy of Ibuprofen as an effective NSAID against inflammatory pain is clinically recognized and supported by pharmacological studies. This signifies that the medication works broadly to suppress the body’s discomfort responses.


Defining the Core: What Type of Medicine is Trifene 400?

Trifene 400 is an NSAID, a pharmacological category recognized for its triple functional capacity to reduce inflammation, relieve pain, and lower elevated body temperature. The preparation is a single-ingredient product, meaning its therapeutic effect is derived exclusively from one component. As a synthetic compound derived from the Propionic acid structure, its efficacy in acute pain management is an established property of the molecule. An official monograph confirms the analgesic and anti-inflammatory classification of this substance.


Active Ingredient and Formulation: What is Trifene 400 Made Of?

The sole active ingredient in Trifene 400 is Ibuprofen, a widely known substance also identified chemically as Isobutylphenylpropanoic acid. This medication is specifically provided as an oral film-coated tablet, a solid dosage form designed for ingestion via the oral route of administration. The film-coating is a differentiating pharmaceutical attribute that facilitates ease of swallowing and ensures the uniform delivery of the active substance, Ibuprofen, alongside inert pharmaceutical excipients necessary to form the tablet structure.


General Purpose: What are the Main Benefits of Trifene 400?

The overarching purpose of Trifene 400 is to provide concurrent relief from pain, inflammation, and fever through a singular systemic action. The drug works by influencing the chemical signals responsible for these symptoms, which makes it generally useful for the temporary management of physical discomfort stemming from various causes, such as muscular strains or headache discomfort. This combined therapeutic capability is the defining benefit of this NSAID, addressing intertwined symptoms simultaneously to improve patient comfort.

What side effects are possible with Trifene 400?

Possible Side Effects and Safety Information

Trifene 400 (Ibuprofen) is associated with a range of officially documented side effects, with the most common generally involving the gastrointestinal tract and the nervous system.

Adverse Reactions by Frequency

Frequency Examples of Documented Reactions
Common Headache, dizziness, dyspepsia, diarrhoea, nausea, vomiting, abdominal pain.
Uncommon Hypersensitivity reactions (e.g., urticaria), rhinitis, insomnia, anxiety, visual impairment, gastritis, gastrointestinal ulceration, abnormal hepatic function, pruritus, nephrotoxicity in various forms.
Rare/Very Rare Agranulocytosis, aplastic anaemia, severe hypersensitivity reactions (anaphylaxis), aseptic meningitis, severe cutaneous adverse reactions (SCARs), severe liver disorder, acute renal failure, cardiac failure, myocardial infarction.

Serious and Clinically Significant Safety Concerns

Serious adverse reactions primarily include the risk of gastrointestinal bleeding, ulceration, or perforation, which can be fatal, particularly in the elderly. The medication is also associated with a small increased risk of arterial thrombotic events, such as myocardial infarction or stroke, especially when used at high doses and long-term.

Severe hypersensitivity reactions and life-threatening skin reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been documented. The drug should be immediately discontinued if signs of a rash, mucosal lesions, or other hypersensitivity reactions occur.


Safety-Related Restrictions and Considerations

Contraindications include severe heart failure, severe renal or hepatic failure, active or recurrent peptic ulcer/haemorrhage, and the last trimester of pregnancy. Adverse effects may be minimized by using the lowest effective dose for the shortest necessary duration. Elderly patients and those with a history of hypertension or heart failure require particular caution due to increased risks of gastrointestinal complications, fluid retention, and oedema.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical attention must be sought for any suspected overdose of Trifene 400. Contacting emergency services is required if severe signs are observed, such as loss of consciousness, respiratory distress, or signs of acute gastrointestinal bleeding.

Overdose manifestations, as documented in regulatory sources, typically involve gastrointestinal and central nervous system (CNS) effects. Common signs may include nausea, vomiting, abdominal pain, headache, tinnitus (ringing in the ears), and drowsiness.

In cases of significant ingestion, more severe outcomes are documented, including metabolic acidosis, hypotension, seizures or convulsions, acute renal failure, and coma. Children may be more susceptible to serious CNS effects following an overdose.

No specific antidote is known for Ibuprofen overdose. Therefore, official management is symptomatic and supportive, focusing on maintaining vital functions. Procedural measures, such as gastric lavage or the administration of activated charcoal, are described in regulatory documents for use within a short period after a potentially toxic ingestion. Hospital monitoring of vital signs and laboratory parameters is mandated for appropriate care.

The official overdose profile is structured around these documented clinical expectations and the non-availability of an antidote, which collectively define the regulatory mandate to seek immediate professional medical assistance upon exposure.

Therapeutic Uses of Trifene 400

What Trifene 400 Treats: Main Uses and Benefits

Trifene 400 (Ibuprofen) is a medication generally used to provide symptomatic relief across key therapeutic domains, addressing groups of symptoms that may interfere with daily functioning. It is applied in clinical settings that involve acute or disruptive symptom patterns, and it helps maintain a sense of stability when symptoms are more noticeable.

It is commonly used across conditions presenting with acute episodes of mild to moderate pain, such as headache, toothache, backache, muscular aches, and for easing discomfort linked to menstrual cramps and minor sprains. It also supports the management of fever and the systemic aches associated with the common cold or flu.

“Trifene 400 assists with maintaining functional stability by easing the overall symptom load during episodes of heightened discomfort.”

The core benefit is in easing the pain and inflammatory symptoms that often cluster together. This application helps address symptoms that may become intense or disruptive, supporting the patient by easing the overall symptom load.


Quick Fact: Relief for Inflammatory Symptoms

Trifene 400 is relevant in contexts where additional symptomatic support is needed to address symptoms related to inflammatory or irritative states, such as swelling and tenderness in joints and soft tissues.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Trifene 400 (Ibuprofen) is an NSAID with specific eligibility rules determined by official regulatory bodies, primarily related to age, physiological status, and underlying health conditions. These rules define who may use the medicine and who must be excluded.

Populations for Whom Use is Contraindicated

Absolute prohibition applies to patients with:

  • Hypersensitivity to Ibuprofen, aspirin, or other NSAIDs.
  • Active or recurrent peptic ulcer/GI haemorrhage or a history of bleeding/perforation related to prior NSAID use.
  • Severe heart failure (NYHA Class IV), severe hepatic failure, or severe renal failure.
  • The last trimester of pregnancy (after 30 weeks gestation) and the setting of coronary artery bypass graft (CABG) surgery.

Age and Condition-Specific Eligibility

Classification Eligibility Rule (Official Labeling)
Pediatric Use The 400 mg tablet strength is generally not recommended for children under 12 years of age [1.4].
Older Adults Use is permitted but requires caution, with treatment starting at the lowest effective dose due to increased risk, especially of GI bleeding [2.2].
Pregnancy/Lactation Contraindicated in the third trimester. During lactation, use is generally preferred but consultation with a health professional is advised [3.3].
Restricted Use Caution is mandatory for patients with uncontrolled hypertension, mild-to-moderate organ impairment (hepatic/renal), or a history of inflammatory bowel disease [1.1, 2.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Trifene 400, which contains the active ingredient Ibuprofen, is subject to several documented interaction patterns as defined in government regulatory labeling. These interactions primarily involve either additive risk (pharmacodynamic effects) or altered plasma concentration (pharmacokinetic effects) of co-administered medicines.


Mandatory Co-Administration Restrictions

Co-administration is strictly restricted for specific substance combinations. The use of Trifene 400 is contraindicated with other nonsteroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors, and with other products containing Ibuprofen. This is due to a documented increased risk of serious gastrointestinal adverse events.


Clinically Significant Interactions

Interacting Agent Official Documented Outcome
Anticoagulants (e.g., Warfarin) Increased risk of serious gastrointestinal bleeding.
Low-dose Aspirin Interferes with its antiplatelet activity, reducing cardioprotection.
Lithium Ibuprofen reduces its renal clearance, increasing its plasma concentration.
Methotrexate Ibuprofen inhibits its clearance, increasing the risk of toxicity.
Diuretics / Antihypertensives Diminished antihypertensive or natriuretic effect.

Timing and Substance Constraints

A specific timing requirement is documented to mitigate the antiplatelet interference with low-dose Aspirin: immediate-release low-dose Aspirin must be administered at least two hours prior to a once-daily regimen of Ibuprofen. Furthermore, regulatory documents note that the risk of serious gastrointestinal bleeding is heightened with the co-ingestion of three or more alcoholic drinks every day while using NSAIDs.

Mechanism of Action

Molecular Targeting of the Cyclooxygenase Pathway

The mechanism initiates with the reversible, non-selective inhibition of the Cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. The active molecule binds to the enzyme site, preventing the synthesis of prostaglandins and related chemical mediators from the Arachidonic Acid Cascade. This targeted molecular action controls the primary upstream step in prostanoid generation.

⬇️ Modulation of Peripheral and Central Signaling

By restricting prostaglandin formation, the drug simultaneously influences two key systems. Peripherally, it decreases the sensitization of nociceptor nerve endings at the site of molecular action, which results in an increased activation threshold for peripheral nociceptor nerve endings. Centrally, the mechanism acts upon the hypothalamus within the brain to reset the elevated body temperature set point, which supports the body's mechanisms for heat dissipation and the establishment of a lower thermal set point.

️ Mechanism Constraints on Selectivity

The non-selective nature of the inhibition mechanism extends its action to both the inducible and constitutive forms of the enzyme, meaning the mechanism also influences homeostatic prostaglandin production. This inherent characteristic of the mechanism involves the modulation of multiple enzyme forms across diverse physiological systems.

Dosage and Administration Information

How to Use Trifene 400

The administration of Trifene 400 (Ibuprofen 400 mg) is governed by official instructions that standardize the route, dose, frequency, and duration of use, consistent with regulatory guidelines. The core principle of use is always to administer the lowest effective dose for the shortest duration necessary to manage symptoms.


Official Administration Guidelines

Usage Parameter Regulatory Instruction
Route of Administration Oral intake
Dosage Form 400 mg film-coated tablet
Standard Single Dose One 400 mg tablet
Maximum Daily Dose For symptomatic self-care, the total dose must not exceed 1200 mg in a 24-hour period. Prescribed use for certain conditions may extend this limit, requiring professional supervision
Frequency Doses may be repeated, but a mandatory minimum interval of 4 to 6 hours must separate administrations

Administration Context and Duration

Trifene 400 tablets should be administered with or immediately after food to enhance gastrointestinal tolerability. The film-coated tablet must be swallowed whole with plenty of fluid; it must not be crushed, chewed, or sucked on. This constraint is tied directly to the proper use of the oral dosage form.

Regulatory labels impose specific time constraints on the duration of use: for the symptomatic management of fever, the use should not exceed 3 consecutive days, and for pain relief, use should generally be limited to 10 days without medical re-evaluation.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Trifene 400

Evidence for Use in Acute Mild to Moderate Pain

The research record for the active ingredient in Trifene 400 includes short-term Randomized Controlled Trials (RCTs), systematic reviews, and meta-analyses. These studies explored how symptoms change over time and examined outcomes related to physical discomfort. Researchers primarily measured symptom intensity using standardized scales.

Studies monitored responses and reported measurements of pain intensity scores over a 2- to 24-hour observation period. Findings describe patterns observed across the adult populations studied. The durability of these observations is not yet clear; long-term patterns of symptom change are not fully established by the core trials.

Evidence for Antipyresis (Fever Reduction)

The substance was studied for elevated body temperature, or fever, in trials that included comparisons against other common antipyretic substances. The studies explored outcomes related to tracking the change in elevated body temperature in cohorts of both febrile adults and children.

These studies reported structured measurements related to changes in core body temperature during the initial 2 to 6 hours following administration. Comparative research describes patterns where the duration of the measured antipyretic effect was similar or marginally different when evaluated against specific alternative agents. Research notes that findings were mixed regarding consistency of measured outcomes across all potential standard agents.

Evidence for Symptomatic Relief of Inflammation

The substance was evaluated in studies involving conditions characterized by fluctuating or episodic manifestations, such as osteoarthritis and primary dysmenorrhea. Studies monitored changes using specialized functional scales, such as the WOMAC index in osteoarthritis, which helps contextualize how patients reported their experience.

Studies reported measurements of functional indices in the populations studied over the trial duration. For chronic inflammatory conditions, research describes the patterns of measured reduction in tenderness and swelling. While the research includes studies that span longer durations, the data gathered often centers on tolerability endpoints; therefore, there is limited information for long-term outcomes on the sustained symptomatic benefit.

What is Still Uncertain About the Research Base

Key limitations identified include that comparative evidence is lacking for certain specific comparisons across every acute pain or fever scenario, leading to some mixed findings reported across different study types. Also, research describing pain intensity measurements has monitored a specific pattern where increasing the quantity of the substance may not correspond with additional measured change in the outcome.

Key Studies & References

  1. Ibuprofen Drug Information, National Library of Medicine (NIH MedlinePlus)
  2. Antipyretic efficacy and safety of Ibuprofen and Acetaminophen in children (Systematic Review)

Frequently Asked Questions (FAQ)

Common questions about Trifene 400 (FAQ)

Q: Is Trifene 400 the same type of medicine as ibuprofen?

A: Trifene 400 is an oral medicine that contains Ibuprofen as its sole active ingredient. This means it belongs to the same class of medicine, known as Nonsteroidal Anti-inflammatory Drugs (NSAIDs). The official product information confirms that its therapeutic effect is derived exclusively from Ibuprofen.

Q: How quickly should I expect to feel relief after using Trifene 400?

A: Official regulatory studies related to the substance indicate that the medicine is rapidly absorbed after ingestion. Peak concentrations in the body are typically reached within one to two hours following administration.

Q: How long does the effect of Trifene 400 typically last?

A: The mandatory minimum interval separating doses is officially set at 4 to 6 hours. This minimum interval is consistent with the general duration of effect described in the administration guidelines for the active ingredient.

Q: Are there any long-term effects associated with using Trifene 400?

A: Regulatory warnings state that long-term continuous use, particularly when high doses are used, may be associated with certain risks. These risks include serious adverse events like arterial thrombotic events (such as heart attack or stroke) and severe gastrointestinal issues.

Q: Why do some people say they take it with food?

A: Regulatory instructions specify that the tablet should be taken with or immediately after food. This administration method is specified as a measure intended to support gastrointestinal tolerability and manage potential stomach irritation.

Q: Why are people with asthma sometimes advised to be cautious with Trifene 400?

A: Official labels require caution because the active ingredient, Ibuprofen, has the potential to cause a severe allergic reaction. This reaction can sometimes manifest as a worsening of asthma symptoms, particularly in individuals who have a known sensitivity to aspirin.

Q: How does the safety profile of Trifene 400 compare to the 200 mg version?

A: Official safety reviews have indicated that the use of up to 1200 mg per day, which encompasses the 400 mg strength, is generally not associated with the increased cardiovascular risks seen with very high, prescription-only daily doses (such as 2400 mg). The overall safety profile depends more on the total daily amount than the single tablet strength.

Q: What is the distinction between a common and a serious side effect of Trifene 400?

A: Regulatory documents classify side effects based on frequency and potential severity of the outcome. Serious side effects carry a high potential for severe health consequences, such as life-threatening gastrointestinal bleeding or acute renal failure. Common side effects, by contrast, are frequently documented, non-life-threatening reactions like a headache or mild upset stomach.

Q: How long does the drug leave the system?

A: The active ingredient has a short elimination half-life, which typically falls in the range of 1.9 to 2.2 hours. Official product information states that the substance is rapidly and completely excreted from the body, primarily by the kidney.

Q: Is Trifene 400 available without a prescription in some countries?

A: Products containing the active ingredient Ibuprofen are available both over-the-counter and by prescription, depending on specific regulatory rules. The 400 mg dosage strength is available without a prescription in some countries, while in others it may require a prescription based on local laws.

Q: Are there known food or drink interactions with Trifene 400?

A: Official regulatory warnings specifically highlight a concern regarding alcohol use while taking this medicine. The risk of serious gastrointestinal bleeding is documented to be heightened with the co-ingestion of three or more alcoholic drinks every day during the use of NSAIDs.

Q: Is there information on using Trifene 400 if a person has kidney concerns?

A: Official safety restrictions describe that caution is required for individuals with existing mild-to-moderate renal (kidney) impairment. The medicine is strictly contraindicated, meaning it must not be used, in cases of severe renal failure.

Q: Can women who are pregnant or breastfeeding typically use Trifene 400?

A: Use is strictly contraindicated during the last three months of pregnancy due to documented risks. For the first two trimesters, and while breastfeeding, consultation with a health professional is generally advised. Official data from sources like LactMed describe that Ibuprofen is a preferred choice during lactation because only extremely low levels are detected in breastmilk.

Q: Does Trifene 400 cause drowsiness?

A: While it is not typically listed as a primary or common side effect, official labels note that dizziness and insomnia are uncommon nervous system effects that may occur. If such effects are experienced, regulatory information may state that activities like driving should be avoided.

Q: Does Trifene 400 contain gluten or lactose?

A: The presence of specific inactive ingredients, such as gluten or lactose anhydrous, is detailed on the official regulatory label for each specific manufacturer's product. This documentation is available to ensure all components of the formulation are known.

Q: Is Trifene 400 known by other brand names internationally?

A: Yes, the active ingredient in Trifene 400, Ibuprofen, is one of the most widely known pain relievers globally. It is marketed under numerous international brand names, including common ones like Advil, Motrin IB, Nurofen, and Brufen.

Q: Are there any age restrictions described for using Trifene 400?

A: Regulatory guidelines specify that the 400 mg tablet strength is generally not recommended for use in children under 12 years of age. Lower strength formulations of the active ingredient are typically utilized for the pediatric population.

Q: Is it true that prolonged use of Trifene 400 can be a concern?

A: Yes, regulatory documents caution that long-term continuous use of the active ingredient can increase the risk of serious adverse events. This is why the product is generally recommended for short-term symptomatic relief only.

Q: Are there any official safety warnings about using Trifene 400 and driving?

A: Official safety warnings often advise caution regarding activities like driving or operating machinery. This is particularly relevant if the user experiences uncommon side effects of the medicine, such as dizziness or visual impairment.

Q: Are there any common reasons why a doctor might prescribe Trifene 400?

A: Physicians may prescribe the active ingredient, Ibuprofen, for the management of chronic inflammatory conditions. Common examples include rheumatoid arthritis, osteoarthritis, and other types of musculoskeletal pain that require high-dose or sustained treatment.

Q: Can Trifene 400 be used for pain relief after dental procedures?

A: Official uses listed in regulatory documents specify that the active ingredient is intended for the temporary relief of minor aches and pains. This documented use includes the relief of toothache and discomfort following dental procedures.

Q: Is there evidence about the safety of Trifene 400 for short-term use?

A: Safety reviews and short-term studies indicate that use for a limited duration, such as up to 10 days at recommended doses is generally described as being associated with a low risk. This includes a generally low risk of developing severe gastrointestinal toxicity or bleeding events.

Q: How does Trifene 400 compare to other non-prescription pain relievers in terms of time to effect?

A: Comparative research has been conducted, primarily to examine the duration of the fever-reducing effect against specific alternative agents. These studies reported outcomes where the effects were described as similar or marginally different when measured across the study cohorts.

Q: Are there any official recommendations regarding when to stop using Trifene 400?

A: Regulatory labels document clear conditions under which immediate discontinuation of the medicine is required. This is mandated if signs of a severe allergic reaction (such as a widespread rash or mucosal lesions) or if symptoms of gastrointestinal bleeding occur.

Q: What are the general expectations for pain reduction when using Trifene 400?

A: Studies monitored symptomatic improvement using standardized pain intensity scales over short observation periods, typically between 2 and 24 hours. The results describe observed patterns of pain reduction across the adult populations that were included in the research.

Q: What kinds of minor headaches is Trifene 400 typically used for?

A: Official regulatory labels specify that the active ingredient is intended for the temporary relief of minor aches and pains. This documented use includes common discomfort associated with general headaches.

Q: What is the main safety concern mentioned in official documents about this drug?

A: The most serious and prominent safety concerns documented in official materials relate to two major risks. These include the potential for fatal gastrointestinal bleeding or ulceration and the increased risk of arterial thrombotic events, such as a heart attack or stroke.

Q: Is it typical for Trifene 400 to cause allergic reactions?

A: Hypersensitivity reactions, such as hives or pruritus (itching), are documented as uncommon side effects of the medicine. Severe allergic reactions are reported as rare or very rare, but regulatory labels mandate immediate discontinuation if they occur.

Q: Can people with a history of heart issues generally use Trifene 400?

A: Official restrictions mandate caution for patients who have a history of conditions such as hypertension or heart failure. The medicine is strictly contraindicated, meaning it is prohibited, for individuals diagnosed with severe heart failure (NYHA Class IV).

Q: Does Trifene 400 have an effect on sleep?

A: The official side effect profile documents that insomnia, which is difficulty sleeping, is listed among the uncommon nervous system side effects of the medicine.

Q: Are there any descriptive cautions for use in the elderly population?

A: Regulatory documents state that caution is required for elderly patients, as they are documented to have an increased risk of developing side effects, particularly serious gastrointestinal complications. Treatment in this population is advised to start at the lowest effective dose.

Q: Is it normal for some people to not feel a significant effect?

A: Research has described patterns suggesting that increasing the amount of the substance used may not consistently correlate with additional measured symptomatic change. This indicates that the individual symptomatic response to the medicine can be variable among different people.

Q: What are the differences between Trifene 400 and similar pain relievers?

A: Official documents include comparative research primarily examining the measured duration of the fever-reducing effects against specific alternative agents. Furthermore, there are mandatory restrictions against co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) due to a documented increased risk of adverse events.

Q: Is Trifene 400 known to interact with herbal supplements?

A: Regulatory and supporting documentation notes that the active ingredient has the potential to interact with certain herbal supplements. This is particularly the case with supplements that possess antiplatelet activity, as their co-administration may increase the risk of bleeding.

How should Trifene 400 be stored and disposed of?

How to Store and Dispose of Trifene 400

The storage and disposal requirements for Trifene 400 (Ibuprofen 400 mg) are defined by official regulatory labeling to ensure product stability and environmental safety.

Storage Requirements

Constraint Official Rule
Temperature Store at a temperature not exceeding 30°C (86°F).
Container Must be kept in the original package to protect from moisture.
Safety Keep out of the sight and reach of children.

Disposal Instructions

Official documents mandate that any unused or expired product must be disposed of in accordance with local requirements for pharmaceutical waste. Disposal via wastewater or household waste is prohibited unless specifically instructed, as the product is documented to pose a risk to the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trifene 400 found in:

A-Z Index: